摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3-hydroxypropylamino)-1-phenacylbenzimidazole hydrobromide | 154055-59-1

中文名称
——
中文别名
——
英文名称
2-(3-hydroxypropylamino)-1-phenacylbenzimidazole hydrobromide
英文别名
2-[2-(3-hydroxypropylamino)benzimidazol-1-yl]-1-phenylethanone;hydrobromide
2-(3-hydroxypropylamino)-1-phenacylbenzimidazole hydrobromide化学式
CAS
154055-59-1
化学式
BrH*C18H19N3O2
mdl
——
分子量
390.28
InChiKey
FZCIGWIRAYULSP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.29
  • 重原子数:
    24
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    67.2
  • 氢给体数:
    3
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    2-(3-hydroxypropylamino)-1-phenacylbenzimidazole hydrobromideC.I.酸性橙108 为溶剂, 反应 4.0h, 以82%的产率得到3-(2-phenyl-1H-imidazo[1,2-a]benzimidazol-1-yl)propan-1-ol
    参考文献:
    名称:
    Research in the field of imidazo[1,2-a]benzimidazole derivatives: XXVII. 1-acylmethyl-2-(ω-hydroxyalkylamino)-benzimidazoles and their transformation into derivatives of tricyclic systems
    摘要:
    1-Acylmethyl-2-(omega-hydroxyalkylamino)benzimidazoles were synthesized and their behavior under various conditions was investigated: at the thermolysis without solvent, at heating in DMF or in 2-aminoethanol, hydrohalic acids, and acetic anhydride, in the presence of chlorinating agents (SOCl(2), POCl(3)). Depending on the reaction conditions derivatives were obtained of 1H-imidazo[1,2-a]-benzimidazole, 9H-2,3-dihydroimidazo[1,2-a]benzimidazole, and 10H-2,3,4,10-tetrahydropyrimido[1,2-a]-benzimidazole that were suitable synthons for the synthesis of functionally substituted derivatives of these tricyclic systems.
    DOI:
    10.1134/s1070428010020223
  • 作为产物:
    描述:
    参考文献:
    名称:
    Benzimidazole compounds
    摘要:
    一种从以下式子(I)中选择的抗糖尿病化合物:##STR1## 其中A、B、C、D、n、R.sub.1、R.sub.2、R.sub.3、R.sub.4、X、Y和Z的定义如说明书所述。含有该化合物的药物。
    公开号:
    US05639756A1
点击查看最新优质反应信息

文献信息

  • US5623073A
    申请人:——
    公开号:US5623073A
    公开(公告)日:1997-04-22
  • US5639756A
    申请人:——
    公开号:US5639756A
    公开(公告)日:1997-06-17
  • Research in the field of imidazo[1,2-a]benzimidazole derivatives: XXVII. 1-acylmethyl-2-(ω-hydroxyalkylamino)-benzimidazoles and their transformation into derivatives of tricyclic systems
    作者:V. A. Anisimova、I. E. Tolpygin、G. S. Borodkin
    DOI:10.1134/s1070428010020223
    日期:2010.2
    1-Acylmethyl-2-(omega-hydroxyalkylamino)benzimidazoles were synthesized and their behavior under various conditions was investigated: at the thermolysis without solvent, at heating in DMF or in 2-aminoethanol, hydrohalic acids, and acetic anhydride, in the presence of chlorinating agents (SOCl(2), POCl(3)). Depending on the reaction conditions derivatives were obtained of 1H-imidazo[1,2-a]-benzimidazole, 9H-2,3-dihydroimidazo[1,2-a]benzimidazole, and 10H-2,3,4,10-tetrahydropyrimido[1,2-a]-benzimidazole that were suitable synthons for the synthesis of functionally substituted derivatives of these tricyclic systems.
  • Benzimidazole compounds
    申请人:Adir et Compagnie
    公开号:US05639756A1
    公开(公告)日:1997-06-17
    An antidiabetic compound selected from those of formula (I): ##STR1## wherein A, B, C, D, n, R.sub.1, R.sub.2, R.sub.3, R.sub.4, X, Y and Z are as defined in the description. Medicaments containing the same.
    一种从以下式子(I)中选择的抗糖尿病化合物:##STR1## 其中A、B、C、D、n、R.sub.1、R.sub.2、R.sub.3、R.sub.4、X、Y和Z的定义如说明书所述。含有该化合物的药物。
查看更多